Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice

Journal of Parasitology

Volumn 94, Issue 5, 2008, Pages 1150-1154

  Robinson, Prema ^a   Martin Jr , Protacio ^a   Garza, Armandina ^a   D'Souza, Melinda ^a   Mastrangelo, Mary Ann ^a   Tweardy, David ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APREPITANT; DEXAMETHASONE; SUBSTANCE P; SUBSTANCE P RECEPTOR;

ANTAGONISM; DIARRHEAL DISEASE; DISEASE TREATMENT; FECES; GLUCOSE; HOST-PATHOGEN INTERACTION; IMMUNOASSAY; INHIBITION; PARASITIC DISEASE; PATHOGENICITY; PHYSIOLOGY; PROTOZOAN; QUANTITATIVE ANALYSIS; RODENT; WEIGHT;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; GLUCOSE INTOLERANCE; HORMONE DETERMINATION; HOST PARASITE INTERACTION; IMMUNE DEFICIENCY; INTESTINE FUNCTION; INTESTINE VILLUS; MOUSE; NONHUMAN; OOCYST; PATHOGENESIS; WEIGHT REDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; CATTLE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FECES; GLUCOSE; IMMUNOSUPPRESSIVE AGENTS; JEJUNUM; MICE; MICE, INBRED C57BL; MICROVILLI; MORPHOLINES; PARASITE EGG COUNT; RANDOM ALLOCATION; RECEPTORS, NEUROKININ-1; SUBSTANCE P; WEIGHT LOSS;

CRYPTOSPORIDIUM PARVUM; MACACA; MURINAE; MUS; PROTOZOA;

EID: 54349120228     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-1458.1     Document Type: Article

References (30)

1. ADJEI, A., J. T. JONES, F. J. ENRIQUEZ, AND S. YAMAMOTO. 1999. Dietary nucleosides and nucleotides reduce Cryptosporidium parvum infection in dexamethasone-immunosuppressed adult mice. Experimental Parasitology 92: 199-208.
2. AGUIRRE, S., L. E. PERRYMAN, W. C. DAVIS, AND T. C. MCGUIRE. 1998. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: Analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection. Journal of Immunology 161: 1891-1900.
3. BERNSTEIN, C. N., M. E. ROBERT, AND V. E. EYSSELEIN. 1993. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease. American Journal of Gastroenterology 88: 908-913.
4. BLUM, A. M., A. METWALI, M. KIM-M ILLER, J. LI, K. QADIR, D. E. ELLIOTT, B. LU, Z. FABRY, N. GERARD, AND J. V. WEINSTOCK. 1999. The substance P receptor is necessary for a normal granulomatous response in murine schistosomiasis mansoni. Journal of Immunology 162: 6080-6085.
5. CHAI, J., S. M. GUK, H. K. HAN, AND C. K. YUN. 1999. Role of intraepithelial lymphocytes in mucosal immune responses of mice experimentally infected with Cryptosporidium parvum. Journal of Parasitology 85: 234-239.
6. CHENG, L., K. R. RASMUSSEN, M. C. HEALEY, AND S. YANG. 1996. Primary and secondary infections with Cryptosporidium parvum in immunosuppressed adult mice. American Journal of Tropical Medicine and Hygiene 55: 324-329.
7. ECKERT, J., R. BRAUN, M. W. SHIRLEY, AND P. COUDERT. 1995. Biotechnology - Guidelines on techniques in coccidiosis research. ECSC-EC-EAEC, Brussels, Belgium, 306 p.
8. GARZA, A., A. LACKNER, P. AYE, M. D'SOUZA, P. MARTIN JR., J. BORDA, D. J. TWEARDY, J. WEINSTOCK, J. GRIFFITHS, AND P. ROBINSON. 2008. Substance P receptor antagonist reverses pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques. Journal of Medical Primatology 37: 109-115.
9. GENTA, R. M., C. L. CHAPPELL, A. C. WHITE, JR., K. T. KIMBALL, AND R. W. GOODGAME. 1993. Duodenal morphology and intensity of infection in AIDS-related intestinal cryptosporidiosis. Gastroenterology 105: 1769-1775.
10. GOODGAME, R. W. 1996. Understanding intestinal spore-forming protozoa: Cryptosporidia, microsporidia, isospora, and cyclospora. Annals of Internal Medicine 124: 429-441
11. _, K. KIMBALL, C. N. OU, A. C. WHITE, JR., R. M. GENTA, C. H. LIFSCHITZ, AND C. L. CHAPPELL. 1995. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 108: 1075-1082.
12. HARP, J. A., W. CHEN, AND A. G. HARMSEN. 1992. Resistance of severe combined immunodeficient mice to infection with Cryptosporidium parvum: The importance of intestinal microflora. Infection and Immunity 60: 3509-3512.
13. HEALEY, M., S. YANG, K. R. RASMUSSEN, M. K. JACKSON, AND C. DU. 1995. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum. Journal of Parasitology 81: 114-116.
14. HERNANDEZ, J., A. LACKNER, P. AYE, K. MUKHERJEE, D. J. TWEARDY, M. A. MASTRANGELO, J. V. WEINSTOCK, J. GRIFFITHS, M. D'SOUZA, S. DIXIT, ET AL. 2007. Substance P is responsible for physiologic alterations such as increased chloride ion secretion and glucose-malabsorption in cryptosporidiosis. Infection and Immunity 75: 1137-1143.
15. HUANG, D., M. C. LOPEZ, J. Y. WANG, F. MARTINEZ, AND R. R. WATSON. 1996. Alterations of the mucosal immune system due to Cryptosporidium parvum infection in normal mice. Cellular Immunology 173: 176-182.
16. _, S. G. YANG, AND J. X. TANG. 2001. Improvement of amplification method for Cryptosporidium parvum oocysts from mice. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 19: 360-362.
17. JURANEK, D. D. 1995. Cryptosporidiosis: Sources of infection and guidelines for prevention. Clinical Infectious Diseases 21(Suppl. 1) S57-61.
18. KANDIL, H. M., H. M. BERSCHNEIDER, AND R. A. ARGENZIO. 1994. Tumour necrosis factor alpha changes porcine intestinal ion transport through a paracrine mechanism involving prostaglandins. Gut 35: 934-940.
19. KAPEL, N., J. F. HUNEAU, D. MAGNE, D. TOME, AND J. G. GOBERT. 1997. Cryptosporidiosis-induced impairment of ion transport and Na+-glucose absorption in adult immunocompromised mice. Journal of Infectious Diseases 176: 834-837.
20. KELLY, P., A. V. THILLAINAYAGAM, J. SMITHSON, J. B. HUNT, A. FORBES, B. G. GAZZARD, AND M. J. FARTHING. 1996. Jejunal water and electrolyte transport in human cryptosporidiosis. Digestive Diseases Sciences 41: 2095-2099.
21. KRUZEL, M. L., Y. HARARI, C. Y. CHEN, AND G. A. CASTRO. 2000. Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice. Inflammation 24: 33-44.
22. LAI, J. P., S. D. DOUGLAS, E. RAPPAPORT, J. M. WU, AND W. Z. HO. 1998. Identification of a delta isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes. Journal of Neuroimmunology 91: 121-128.
23. LAMBRECHT, B. N., P. R. GERMONPRE, E. G. EVERAERT, I. CARRO-MUINO, M. DE VEERMAN, C. DE FELIPE, S. P. HUNT, K. THIELEMANS, G. F. JOOS, AND R. A. PAUWELS. 1999. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. European Journal of Immunology 29: 3815-3825.
24. MAZUMDAR, S., AND K. M. DAS. 1992. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease. American Journal of Gastroenterology 87: 176-181.
25. MENG, Z. H., K. DYER, T. R. BILLIAR, AND D. J. TWEARDY. 2000. Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock. Shock 14: 41-48.
26. METWALI, A., A. M. BLUM, D. E. ELLIOTT, T. SETIAWAN, AND J. V. WEINSTOCK. 2004. Cutting edge: Hemokinin has substance P-like function and expression in inflammation. Journal of Immunology 172: 6528-6532.
27. _, L. FERRARIS, J. S. KLEIN, C. FIOCCHI, AND J. V. WEINSTOCK. 1994. Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. Journal of Neuroimmunology 52: 69-78.
28. ROBINSON, P., P. C. OKHUYSEN, C. L. CHAPPELL, J. V. WEINSTOCK, D. E. LEWIS, J. K. ACTOR, AND A. C. WHITE, JR. 2003. Substance P expression correlates with severity of diarrhea in cryptosporidiosis. Journal of Infectious Diseases 188: 290-296.
29. SONEA, I. M., M. V. PALMER, D. AKILI, AND J. A. HARP. 2002. Treatment with neurokinin-1 receptor antagonist reduces severity of inflammatory bowel disease induced by Cryptosporidium parvum. Clinical Diagnostic Laboratory Immunology 9: 333-340.
30. SOZMEN, M., P. J. BROWN, AND P. J. CRIPPS. 1999. Quantitation of histochemical staining of salivary gland mucin using image analysis in cats and dogs. Veterinary Research 30: 99-108.